207 related articles for article (PubMed ID: 38344334)
21. Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015.
Novosad SA; Mu Y; Winston LG; Johnston H; Basiliere E; Olson DM; Farley MM; Revis A; Wilson L; Perlmutter R; Holzbauer SM; Whitten T; Phipps EC; Dumyati GK; Beldavs ZG; Ocampo VLS; Davis CM; Kainer M; Gerding DN; Guh AY
J Gen Intern Med; 2020 Feb; 35(2):412-419. PubMed ID: 31768906
[TBL] [Abstract][Full Text] [Related]
22. Treatment of
Oksi J; Anttila VJ; Mattila E
Ann Med; 2020; 52(1-2):12-20. PubMed ID: 31801387
[No Abstract] [Full Text] [Related]
23. Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
Gentry CA; Campbell DL; Williams RJ
Int J Antimicrob Agents; 2021 Mar; 57(3):106282. PubMed ID: 33465458
[TBL] [Abstract][Full Text] [Related]
24. Incidence of Clostridioides difficile infection at a Saudi Tertiary Academic Medical Center and compliance with IDSA/SHEA, ACG, and ESCMID guidelines for treatment over a 10-year period.
Aljafel NA; Al-Shaikhy HH; Alnahdi MA; Thabit AK
J Infect Public Health; 2020 Aug; 13(8):1156-1160. PubMed ID: 32276872
[TBL] [Abstract][Full Text] [Related]
25.
Al Naser Y; AlGashami M; Aljashaami L
Prz Gastroenterol; 2024; 19(1):1-5. PubMed ID: 38571533
[No Abstract] [Full Text] [Related]
26. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
Pipek B; Valentová H; Fojtík P; Urban O
Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
[TBL] [Abstract][Full Text] [Related]
27. [Clostridioides difficile - New Insights and Therapy Recommendations].
Schönherr S; Jung L; Lübbert C
Dtsch Med Wochenschr; 2023 Jun; 148(12):752-758. PubMed ID: 37257477
[TBL] [Abstract][Full Text] [Related]
28. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.
Nelson RL; Suda KJ; Evans CT
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004610. PubMed ID: 28257555
[TBL] [Abstract][Full Text] [Related]
29. Clostridium difficile infection in older adults: a review and update on its management.
Kee VR
Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in the treatment of
Khurana S; Kahl A; Yu K; DuPont AW
Fac Rev; 2020; 9():13. PubMed ID: 33659945
[No Abstract] [Full Text] [Related]
31. Cutting edges in Clostridioides difficile infections.
Durovic A; Tschudin-Sutter S
Swiss Med Wkly; 2021 Sep; 151():w30033. PubMed ID: 34652093
[TBL] [Abstract][Full Text] [Related]
32. Navigating the 2021 update to the IDSA/SHEA
Shoff CJ; Spires SS; Yen C; Advani SD
Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e70. PubMed ID: 36483335
[TBL] [Abstract][Full Text] [Related]
33. Comparison of three current Clostridioides difficile infection guidelines: IDSA/SHEA, ESCMID, and ACG guidelines.
Thabit AK; Alsolami MH; Baghlaf NA; Alsharekh RM; Almazmumi HA; Alselami AS; Alsubhi FA
Infection; 2019 Dec; 47(6):899-909. PubMed ID: 31428991
[TBL] [Abstract][Full Text] [Related]
34. Therapeutics for
Khanna S; Voth E
Expert Rev Gastroenterol Hepatol; 2023; 17(9):903-911. PubMed ID: 37606962
[TBL] [Abstract][Full Text] [Related]
35. How to: prophylactic interventions for prevention of Clostridioides difficile infection.
Reigadas E; van Prehn J; Falcone M; Fitzpatrick F; Vehreschild MJGT; Kuijper EJ; Bouza E;
Clin Microbiol Infect; 2021 Dec; 27(12):1777-1783. PubMed ID: 34245901
[TBL] [Abstract][Full Text] [Related]
36. Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria.
Starzengruber P; Segagni Lusignani L; Wrba T; Mitteregger D; Indra A; Graninger W; Presterl E; Diab-Elschahawi M
Wien Klin Wochenschr; 2014 Jul; 126(13-14):427-30. PubMed ID: 24903143
[TBL] [Abstract][Full Text] [Related]
37. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).
McDonald LC; Gerding DN; Johnson S; Bakken JS; Carroll KC; Coffin SE; Dubberke ER; Garey KW; Gould CV; Kelly C; Loo V; Shaklee Sammons J; Sandora TJ; Wilcox MH
Clin Infect Dis; 2018 Mar; 66(7):987-994. PubMed ID: 29562266
[TBL] [Abstract][Full Text] [Related]
38. Fecal pharmacokinetics/pharmacodynamics characteristics of fidaxomicin and vancomycin against Clostridioides difficile infection elucidated by in vivo feces-based infectious evaluation models.
Tashiro S; Taguchi K; Enoki Y; Matsumoto K
Clin Microbiol Infect; 2023 May; 29(5):616-622. PubMed ID: 36574949
[TBL] [Abstract][Full Text] [Related]
39. Updates on
Grace E; Chahine EB
Sr Care Pharm; 2019 Jan; 34(1):29-42. PubMed ID: 30821676
[TBL] [Abstract][Full Text] [Related]
40. Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis.
Cappetto CM
Am J Health Syst Pharm; 2021 Jul; 78(15):1374-1381. PubMed ID: 33851215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
